Human Capital Benefits participates in Canadian Leadership Council on Drug Plan Partnerships

Chris Pryce of Human Capital Benefits was chosen to attend a council meeting with selected advisors/consultants, pharmacy and drug manufacturers to review presentations on evidence informed decision making through the Private payer lens, plan sponsor obligations and pharmacogenics.  There will be a report published for Benefits Canada in Summer 2021.

Insights

More Related Articles

The here and now of pharmacogenetic testing

2025 Canadian Leadership Council on Drug Plan Partnerships

e2r Blog Post Alerts – Sick Notes